Loading clinical trials...
Loading clinical trials...
Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy in Patients With NSAIDs and Low Dose Steroid: A Single-center, Randomized, Open Labeled, Pilot Study
Conditions
Interventions
Eupatilin
Rebamipide
Start Date
June 1, 2021
Primary Completion Date
December 31, 2021
Completion Date
January 31, 2022
Last Updated
May 13, 2021
NCT07484243
NCT07153471
NCT06647069
NCT06841562
NCT07351968
NCT06381791
Lead Sponsor
Seoul National University Boramae Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions